Pharos Pharmaceutical Oriented Services Ltd.

2 trials Commercial sponsor Merged from 2 name variants

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Countries active

0 Unique IMPs

100% Results reported

Other

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

All trials

2 total

Bioequivalence of Cladribine 10 mg from two different products Ended

2023-508656-19-00 1 country
Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects … Ended

2025-522252-74-00 1 country

Showing 1–2 of 2 trials

← All sponsors A–Z